That's how researcher Beatriz Garcia Nice describes the new U.S. stance under the Trump administration to programs addressing gender-based violence.

Mifepristone is facing another major legal challenge.

A pilot program at the Open Doors transitional home, a Rhode Island not-for-profit, has offered the drugs to 18 of its residents, many of whom say the GLP-1s, along with the other supports offered there, have changed their lives.

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's also beneficial because the HIV virus is always evolving.

People are turning to AI chatbots to help them with medical advice. Recent studies suggest these bots are not always helpful in making decisions about health.

Outside of Chicago, a homeless shelter and rehab center called Wayside Cross hosts a unique program to help people get back on their feet, one mile at a time.

The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative treatment for cancer. It is as politically polarizing as ever.

As more people stay active as they age, overuse injuries are increasing. A non-invasive treatment known as shockwave therapy can help ease heel and elbow pain. Here's how.

In Minneapolis, underground healthcare networks of volunteer doctors and nurses bring care into the homes of families too scared of immigration enforcement to seek help.

She was thrilled to become the first teacher from a government-sponsored school in India to get a Fulbright exchange award to learn from U.S. schools. People asked two questions that clouded her joy.